Skip to Content

Prostate-Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy

Objective

Genitourinary: RTOG 0815 A Phase II Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

The purpose of this study is to compare the effects of dose-escalated radiation therapy with or without hormone therapy on your prostate cancer. Prior studies have suggested possible advantages to the administration of hormonal therapy with radiation. However, those studies were performed with radiation techniques that do not match those commonly used in clinical practice today (that is, dose-escalated radiotherapy). Therefore, we will be testing to see if similar benefits for hormonal therapy are seen when used with current radiation therapy techniques.

Contact
Rebecca Denofer, RN, OCN at 802-747-1692
or rdenofer@rrmc.org

Rutland Regional Medical Center
160 Allen Street
Rutland, VT 05701
802.775.7111

Facebook YouTube LinkedIn CarePages Twitter